Perceptive Advisors LLC Immatics N.V. Transaction History
Perceptive Advisors LLC
- $3.83 Billion
- Q3 2024
A detailed history of Perceptive Advisors LLC transactions in Immatics N.V. stock. As of the latest transaction made, Perceptive Advisors LLC holds 8,086,159 shares of IMTX stock, worth $57.7 Million. This represents 2.41% of its overall portfolio holdings.
Number of Shares
8,086,159
Previous 8,086,159
-0.0%
Holding current value
$57.7 Million
Previous $94 Million
1.81%
% of portfolio
2.41%
Previous 2.72%
Shares
4 transactions
Others Institutions Holding IMTX
# of Institutions
101Shares Held
75.8MCall Options Held
238KPut Options Held
727K-
Rtw Investments, LP New York, NY10MShares$71.3 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$69 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$52.6 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$45.9 Million0.79% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.9MShares$27.8 Million1.61% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $543M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...